About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Sessions's War on the Cole Memo and the New Frontier for the Canna-IP Industry | Main | Webinar on Drafting Software Patents to Survive § 101 and AIA Challenges »

January 06, 2018

Webcast on Paragraph IV Litigation

The Knowledge GroupThe Knowledge Group will offer a webcast entitled "Paragraph IV Litigation: Best Practices and Practical Tips in 2018" on January 31, 2018 from 3:00 to 4:00 pm (ET).  Paul B. Sudentas of Locke Lord LLP and Nigamnarayan Acharya of Baker Donelson will provide an in-depth analysis of the current trends and recent updates involving case filings, and also provide attendees with best practices and practical strategies to help overcome the evolving legal climate and year to come.  Key topics to be addressed by the webcast include:

• Abbreviated New Drug Application (ANDA) – Legal Overview
• Recent Updates and Developments
• 2018 Legal Roadmap for Paragraph IV Litigation
• Paragraph IV and Its Relationship with:
    -- The Food and Drug Administration Reauthorization Act (FDARA)
    -- The Generic Drug User Fee Amendments (GDUFA)
• Best Practices and Practical Tips

The registration fee for the webcast is $49.  Those interested in registering for the webinar can do so here.

Posted at 11:45 PM in Conferences & CLE's |

Comments

The comments to this entry are closed.

April 2025

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Categories

Archives

More...